Goldwater Institute’s right-to-try bill gets second life

‘It’s not false hope; It is hope,’ said Rep. Andy Biggs (R-Ariz.)

By Sarah Karlin-Smith | Politico

The House of Representatives passed on party lines Wednesday evening a bill designed to let very sick patients request access to experimental medicines without government oversight.

The passage of the bill, known as right-to-try, is a big victory for the small libertarian think tank that crafted the proposal — and for a White House that has vigorously campaigned for the law. And it comes one week after Republicans failed to pass a similar measure through an expedited process that needed two-thirds support from the chamber.

The bill passed by a vote of 267-149 with 35 Democrats in favor and two Republicans against. It now heads to the Senate, which passed a slightly different version of the legislation last summer. With a final law all but assured, health policy advocates who have vigorously opposed the idea are now looking toward the broader anti-regulatory health agenda being pushed by the Goldwater Institute.

READ ON:

Share this!

Additional Articles

Get Our Twice Weekly Newsletter!

* indicates required

Rose Law Group pc values “outrageous client service.” We pride ourselves on hyper-responsiveness to our clients’ needs and an extraordinary record of success in achieving our clients’ goals. We know we get results and our list of outstanding clients speaks to the quality of our work.

News Categories